ATE303136T1 - Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung - Google Patents

Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung

Info

Publication number
ATE303136T1
ATE303136T1 AT00925209T AT00925209T ATE303136T1 AT E303136 T1 ATE303136 T1 AT E303136T1 AT 00925209 T AT00925209 T AT 00925209T AT 00925209 T AT00925209 T AT 00925209T AT E303136 T1 ATE303136 T1 AT E303136T1
Authority
AT
Austria
Prior art keywords
anhydrous
ranitidine hydrochloride
composition
tablet containing
coated tablet
Prior art date
Application number
AT00925209T
Other languages
English (en)
Inventor
Paolo Alberto Veronesi
Emanuela Peschechera
Dotti Xavier Cirera
Original Assignee
Pharmexcel Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmexcel Srl filed Critical Pharmexcel Srl
Application granted granted Critical
Publication of ATE303136T1 publication Critical patent/ATE303136T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00925209T 1999-04-12 2000-04-11 Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung ATE303136T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000740A IT1311915B1 (it) 1999-04-12 1999-04-12 Compressa anidra di cloridrato di ranitidina con rivestimento a doppiostrato e sua composizione.
PCT/EP2000/003330 WO2000061118A1 (en) 1999-04-12 2000-04-11 Anhydrous tablet of ranitidine hydrochloride with double-layer coating and its composition

Publications (1)

Publication Number Publication Date
ATE303136T1 true ATE303136T1 (de) 2005-09-15

Family

ID=11382663

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00925209T ATE303136T1 (de) 1999-04-12 2000-04-11 Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung

Country Status (6)

Country Link
EP (1) EP1171102B1 (de)
AT (1) ATE303136T1 (de)
AU (1) AU4400500A (de)
DE (1) DE60022334D1 (de)
IT (1) IT1311915B1 (de)
WO (1) WO2000061118A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG65305B1 (bg) * 2001-06-05 2008-01-31 "Унифарм" Ад Лекарствена форма, съдържаща ранитидин
CN105030694A (zh) * 2015-08-04 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃溃疡的药物盐酸雷尼替丁组合物干混悬剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171127B1 (da) * 1994-04-22 1996-06-24 Gea Farmaceutisk Fabrik As Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk
DE69504156T2 (de) * 1994-06-24 1998-12-24 Ranbaxy Lab Ltd Verfahren zur Herstellung von Ranitidinhydrochlorid in der Kristallform 1
US5853756A (en) * 1995-01-11 1998-12-29 J. B. Chemicals & Pharmaceuticals Limited Controlled release formulations of Ranitidine
DE19511131A1 (de) * 1995-03-27 1996-10-02 Basf Ag Mechanisch stabile feste Wirkstoffzubereitungsformen

Also Published As

Publication number Publication date
DE60022334D1 (de) 2005-10-06
AU4400500A (en) 2000-11-14
EP1171102A1 (de) 2002-01-16
EP1171102B1 (de) 2005-08-31
WO2000061118A1 (en) 2000-10-19
ITMI990740A1 (it) 2000-10-12
IT1311915B1 (it) 2002-03-20

Similar Documents

Publication Publication Date Title
EA200400471A1 (ru) Оральная дозированная форма пропиверина
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
CA2316485A1 (en) Sustained-release pharmaceutical composition
CA2382098A1 (en) Sustained-release, oral pharmaceutical forms of administration
CA2251886A1 (en) An oral pharmaceutical formulation containing ibandronate
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
ATE158504T1 (de) Brausemischungen enthaltend ibuprofen und verfahren
KR910014120A (ko) 피모벤단의 경구용 약제학적 제제
UA35604C2 (uk) Фармацевтична композиція з антидепресивною активністю
EP1619180A4 (de) Casr-antagonist
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
SE0102440D0 (sv) New compound
ID22763A (id) Komposisi penstabil tibolon
PL337279A1 (en) Pharmaceutical with controlled releose containing inhibitor ace as an active substance
CA2353693A1 (en) Pharmaceutical composition containing citalopram
ATE303136T1 (de) Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung
KR890006236A (ko) 피페리디노 알칸올-충혈제거제 조합을 위한 약제학적 조성물
BE2016C017I2 (de)
GEP20043377B (en) Pharmaceutical Complex
NO20013601L (no) Nye morfolinobenzamidsalter
MXPA02006250A (es) Derivados de butino diol.
NZ505080A (en) Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid
ATE258046T1 (de) Pharmazeutische, metamizol enthaltende brauseformulierung
MY101266A (en) Pharmaceutical formulations
HUP9802437A3 (en) 5-pyrazolylbenzoic acid derivatives, herbicidal, desiccant and defoliant compositions containing these compounds as active ingredients, preparation and use of the latest

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties